Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New David Lazar Shell Play $EAIN
___________________________________________________________________________________________
Shell Monster Stocks **Shell - Custodian - Material Event Plays** (SHELL)
https://investorshub.advfn.com/Shell-Monster-Stocks-**Shell-Custodian-Material-Event-Plays**-37363/
I have no idea what is going on with EAIN, but I just blew out my long for a profit.
I'm sure I will regret it, but right now I feel great!!!!!!!!!!!!!!
Anybody have any idea what is going on with EAIN?
Please explain what that means?
I know its been almost a year and a half, but do you still own this.
It actually printed on the offer yesterday.........
I actually have a small position and I noticed it printed yesterday.
Man if this thing could ever get going again?
No idea, but I have a left over position that I hoping (actually praying) that it goes higher so I can possibly make back some of my losses or in an alternate universe make something..................
Who could be buying? Ain't much money. I lost a boatload of money on this baby
This thing actually printed today!!!!!
This thing actually printed today!!!!!
So this ride is completely over? Way to kill it, Loke.
I love the way the DD about this is all removed now.
I’m not sure this is over? But we sure don’t have any information and I sure don’t have any chairs now. So many great loss.
No. I finally dumped at .60 or something like that for a major tax write off. Smh. Smh.
Anyone still in this piece of garbage? No filings since March. Do you think they just gave up?
Probably but once they do......
Yep. Saw that the other day. I don’t think it’s them selling though. I think it’s the shareholders who have been here since last year.
During the nine months ended December 31, 2017, the Company issued 1,000,000 shares (post reverse split) of common stock for conversion of note payable and stock based compensation.
I agree with that. Only mean that it’s insane that they bought a shell just to do this to it.
Damn. 10% of the company would now cost $4k. Smh. I remember when my shares would have been double that.
It is bad, but hardly insane. It is perfectly rational. The company has said nothing and done nothing since the reverse split and name change.
If they actually complete the merger, the stock should do well. But I would imagine everyone has given up hope.
BUX
Wow. Insane. Raining shares since the $6 range. Wtf.
EAIN is a total disaster. The ask is now .60. No merger, no press releases, no filings, collapsing stock price.....
Why are you accumulating? Am I missing something?
I'm here and still accumulating!!!
Other than the very few with the float, anybody have any more shares of this to sell? Or is everyone gone now?
Damn. Someone has to have accumulated about 15% of the Float by now.
WELL AT LEAST THEY HAVE A FACEBOOK SITE!!!
THAT'S WHY WE INVEST, AS YOU NEVER KNOW WHAT TOMORROW WILL BRING!!!
Wow, guys, this is a bit of a disaster. Is Loke still alive? Over there can't you give happy birthday to ancestors?
I see that most of the ardent supporters have left the coral and are no longer Mods.
No I didn’t notice and now I’m blocked...
This was my message... limited characters like twitter...
If I may be so bold to inquire about this Enabling Asia/EAIN, Stock price down 700%.
According to NVSOS you still the man in charge.
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=%252bnNW3Lb8WSUYl9ZU5hjo2g%253d%253d&nt7=0
Stop sign up!!! Overdue reports!!!
https://www.otcmarkets.com/stock/EAIN/quote
Is this shell going to be utilized? Can we get any communication from you or the company about what is going on?
Thank you for your time and consideration.
He posted happy birthday to Loke on his IG Story. I screenshot it. Will send it to Ninja. Says happy birthday from all of us at Enabling Asia.
Anybody else notice a lot of his pics are in Iowa? Meaning he’s here.
Anyone else get blocked by kewell yap?
IG kewellmy
30 minutes ago... they all liked their post... they awake or automating their social media?
https://www.facebook.com/321880117890678/posts/2041021719309834/
Lol...
Considered him trolled...
Down 700% you’d think they’d answer. Found kewell yaps also...
https://www.instagram.com/kewellmy
Tomorrow I'll be buying... I'll give EAIN and U Mobile till the end of the year to get their merger act together, hehheh.
I see our little troop is dwindling down to a bare ass quorum. At least the float is only 75,000 and I doubt any stupid MM's are shorting it, haha. Wow, don't to accumulate too much of a good thing. My Mom told me to light on the sugar.
Best of luck to all longs...
That guy has a chin on him lol
Also, that's the Loke profile I've been messaging and surprisingly things have been happening when you troll him a little.
-CN
Haven’t tried Instagram...
Anyone know who this guy is?
https://www.instagram.com/tonycssoh
https://www.instagram.com/enablingasia
https://www.instagram.com/lokesiong
I sent Loke a private message on Instagram which has actually been pretty successful. He doesn't talk, but I've noticed that when I messaged him on the website it was then fixed the next day.
Waiting on the financials for the 1Q 2018 still, so we shall see.
-CN
Lack of patience... lack of filings... lack of communication... lack of existence...
Anyone see anything with a 2018 date with Loke name on it?
He seems to like his Buzzme FB posts.
Kewell yap has no shares but he like enabling asia FB posts.
So looks like this shell has nothing to do with enabling asia, Tron, or umobile.
TGRP repeat...
I agree something negative going on, the stock stood firm around $7+ for months after the merger. All of a sudden its diving...WHY??????
My worst case spin on this is that:
EA bought the shell in hopes of eventually having someone else take over.
They RS and bring the price at a good point where they can sell and take it back down making measly profits.
Then when the other entity buys or takes over the shell then they RS again essentially wiping out all our money then they will start to pump the crap.
Very disappointed to say the least. Don't know at all if this will happen but I see no more hope for this company. Something changed along the way.
Agree with you there.
EAIN was trading at $7 as recently as May of this year. Hard to believe an 80%+ decline in a few months isn't telling us something negative is going on behind the scenes.
You would think management would at least have the decency to put out a single press release to inform investors of their plans and to stop the collapse in the stock.
But they don't. That is telling.
BUX
Someone just bought 1,000 shares. I know there were also restrictions on the new owners for 1 year. I’m wondering if they’re waiting for that 1 year expiration prior to starting to do things correctly.
I can’t believe they would buy a shell and not do something with it. Too much of an investment for that.
What a freaking shame, should have sold when they didn't respond to my last 2 emails. Just goes to show that no matter how good it sounds or looks you just don't trust a quiet company or CEO.
Why would anyone want shares? EAIN is an empty shell. It has been 7 months since the name change and reverse split and they still haven't merged the operating company into the shell.
The collapse in the stock price in the last few months should provide a pretty good indication that the merger won't happen.
I hope I am wrong, but I have seen no positive signs from this company at all in 2018. No news, no merger, only one public filing, which shows virtually no assets and no revenue.
Current market cap is around $1.2 million, assuming no recent dilution.
That is pretty expensive for an empty shell. They generally go for between $250,000 and $500,000.
Let's see if they even bother to file another quarterly or annual report.
Hopefully they will at least continue to file to maintain the value of the shell.
BUX
Followers
|
58
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4425
|
Created
|
11/19/09
|
Type
|
Free
|
Moderators |
JERUSALEM and PHOENIX, June 23, 2020 /PRNewswire/ -- Mirror Biologics, Inc. (Phoenix, AZ), the commercial development arm of Immunovative Therapies, Ltd. (Jerusalem, IL) (together "the Company"), a clinical-stage company specialized in the development, manufacturing and clinical translation of next-generation immunotherapy drugs where the active ingredients are living immune cells, today announced that the U.S. Food and Drug Administration (FDA) has cleared our Phase I/II universal virus vaccine clinical trial under the Company's second active Investigational New Drug (IND) application enabling use of the Company's lead experimental drug, AlloStim®, for testing as an anti-viral prophylaxis drug.
AlloStim® is an off-the-shelf, non-genetically manipulated, patented living immune cell with multiple immunodulatory properties, currently being tested under a separate IND as a therapeutic vaccine for chemotherapy-refractory metastatic cancers.
This Phase I/II trial is believed to be the first anti-viral vaccine in clinical development that is specifically targeted to protect the elderly. The elderly are the most vulnerable in our society to the severe and lethal effects of respiratory viral infections which cause disease complications such as pneumonia. Pneumonia is the single most common cause of death from infectious disease in those over 65 years old. The chance that a COVID-19 patient will develop symptoms severe enough to require hospitalization and respiratory support rises sharply with age and the death rate due to COVID-19 is disproportionately higher in our senior citizens.
Dr. Michael Har-Noy, founder and CEO stated: "We are pleased to have FDA clearance of our novel universal viral vaccine clinical trial targeted to healthy adults over 65 years old. There is a large unmet need to protect the elderly from the devastating effects of respiratory viral infection. If we can protect the elderly from COVID-19, economies can open safely and herd immunity can be allowed to develop without an alarming increase in death rate. Even if a COVID-19 vaccine is developed, it is likely, as with influenza vaccines, that it will be less effective in the elderly where protection is most needed. In addition, a successful COVID-19 vaccine is vulnerable to weakening upon mutation of the virus and will not protect against future novel viral outbreaks. Our universal vaccine technology is designed to protect against any type of viral infection without the requirement to have prior knowledge of the viral structure and is specifically designed to work in the weakened senescent immune systems of the elderly and frail."
The Phase I/II clinical trial will accrue 40 healthy adults over age 65. Volunteers will receive five (5) intradermal injections of AlloStim® over 14 days. Blood samples will be collected prior to injection and at 30 days, 6 months and 1 year after injection. The blood will be challenged in the laboratory with a panel of live viruses, including the COVID-19 virus and influenza viruses in order to determine if the remodeled immune system can suppress the propagation of these viruses in cultures of human endothelial cells from the respiratory tract.
Details of the clinical trial can be found on the National Institutes of Health ClinicalTrials.gov registry: ClinicalTrials.gov Identifier: NCT04441047
The universal viral protection mechanism has been reversed engineered from the immune response that results in asymptomatic viral clearance in youthful individuals. Using a novel, patent-pending technology called "allo-priming", the youthful immune response is imprinted upon the elderly immune system so that it can be ready to be activated upon encounter with any virus. The mechanism creates conditions for an "in-situ" vaccine providing viral-specific protection and memory to prevent re-infection from the same virus. The novel mechanism has been described in a peer-reviewed article published in the Journal of Translational Medicine which can be viewed by following this link.
AlloStim® is derived from precursor cells purified from the blood of healthy donors. The Company will be working to scale up and automate the production process in parallel with on-going clinical trials so that upon demonstration of safety and efficacy, the vaccine can be quickly scaled-up to quantities necessary to protect the elderly population. Today, there is estimated to be more than 46 million adults age 65 and older living in the USA.
Media Contact:
Dr. Michael Har-Noy
Phone: 1-760-216-7494
email: harnoy@immunovative.com
Related Images
Mirror Biologics
Mirror Biologics, Inc (Phoenix) is the commercial development arm of Immunovative Therapies, Ltd. (Israel)
Related Links
SOURCE Immunovative Therapies, Ltd.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |